title: Obstructive ileus of large bowel is associated with low tissue levels of neuropeptides in prestenotic bowel segment.
abstract: The neuropeptides substance P, vasoactive intestinal polypeptide, and the recently discovered peptide secretoneurin are neurotransmitters of the intrinsic nervous system of the gut and effect gut motility. The aim of this study was to investigate whether these neuropeptides are involved in the pathophysiology of large bowel ileus. Five patients underwent colonic resections for obstructive cancer of the colon. Full-thickness specimens of the resected colon were taken 10 cm proximal and 10 cm distal to the site of tumor obstruction. Substance P-, vasoactive intestinal polypeptide-, and secretoneurin-like immunoreactivities were measured in the specimens by radioimmunoassay. In addition immunocytochemistry was performed. Tissue levels of substance P, vasoactive intestinal polypeptide, and secretoneurin were lower in the prestenotic than in the poststenotic bowel segment. In accordance, immunocytochemistry revealed a denser staining of ganglion cells and fibers for all three neuropeptides in the poststenotic bowel. The decreased tissue levels of substance P, vasoactive intestinal polypeptide, and secretoneurin in the prestenotic bowel segment may contribute to the final decompensation of obstructive ileus.
authors.affiliation: Second Department of Surgery, University of Innsbruck, Austria.
authors.forename: R
authors.initials: R
authors.lastname: Prommegger
authors.forename: J
authors.initials: J
authors.lastname: Marksteiner
authors.forename: G
authors.initials: G
authors.lastname: Wetscher
authors.forename: J
authors.initials: J
authors.lastname: Tschmelitsch
authors.forename: U
authors.initials: U
authors.lastname: Eder
authors.forename: R
authors.initials: R
authors.lastname: Fischer-Colbrie
authors.forename: A
authors.initials: A
authors.lastname: Saria
authors.forename: E
authors.initials: E
authors.lastname: Bodner
mesh_terms: D000368:Aged; D003106:Colon / Q000294:innervation / Q000378:metabolism; D003108:Colonic Diseases / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D003110:Colonic Neoplasms / Q000150:complications; D017615:Enteric Nervous System / Q000378:metabolism / Q000503:physiopathology; D005260:Female; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D009479:Neuropeptides / Q000378:metabolism*; D053381:Secretogranin II; D013373:Substance P / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism
chemical_list: D009479:Neuropeptides; D053381:Secretogranin II; C081159:secretoneurin; D013373:Substance P; D014660:Vasoactive Intestinal Peptide